II
RDHL

Ibex Investors’s Redhill Biopharma RDHL Stock Holding History

Ibex Investors’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-262
Closed -$675K – 51
2021
Q4 		$675K Sell
262
-453
-63% -$1.81M 0.23% 33
2021
Q3 		$3.28M Sell
715
-256
-26% -$1.74M 0.69% 18
2021
Q2 		$6.68M Sell
971
-1,246
-56% -$8.6M 2.48% 7
2021
Q1 		$16.2M Buy
2,217
+324
+17% +$2.72M 5.57% 7
2020
Q4 		$15.3M Buy
1,893
+17
+0.9% +$153K 6.1% 8
2020
Q3 		$19.2M Buy
1,876
+6
+0.3% +$49.2K 10.09% 3
2020
Q2 		$12.5M Buy
1,870
+20
+1% +$138K 5.95% 8
2020
Q1 		$8.38M Buy
1,850
+97
+6% +$485K 8.44% 7
2019
Q4 		$10.6M Sell
1,753
-104
-6% -$665K 0.2% 8
2019
Q3 		$13.1M Sell
1,857
-10
-0.5% -$72.8K 0.82% 11
2019
Q2 		$12.1K Buy
1,867
+891
+91% +$6.86M 0.99% 14
2019
Q1 		$8.11M Buy
976
+37
+4% +$293K 0.72% 12
2018
Q4 		$5.21M Buy
939
+412
+78% +$3.16M 0.85% 11
2018
Q3 		$4.65M Buy
527
+27
+5% +$220K 2.58% 10
2018
Q2 		$4.26M Buy
500
+49
+11% +$312K 2.42% 11
2018
Q1 		$2.32M Buy
451
+7
+2% +$40.3K 1.91% 13
2017
Q4 		$2.28M Buy
+444
New +$2.99M 1.33% 9

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Ibex Investors's RDHL Position: Q1 2022 in Review

Ibex Investors sold out of Redhill Biopharma (RDHL) in Q1 2022, closing a stake of 262 shares — an estimated $675K sold.

Ibex Investors first reported a position in RDHL in Q4 2017 and held it in 17 quarters. The position peaked at $19.2M in Q3 2020. 43 funds tracked by Wall St. Rank hold RDHL as of Q1 2022.

  • Ibex Investors reported no remaining Redhill Biopharma position as of Q1 2022 after selling out during the quarter.
  • Ibex Investors sold 262 Redhill Biopharma shares in Q1 2022, an estimated $675K.
  • Ibex Investors first reported a position in Redhill Biopharma in Q4 2017 and held it in 17 quarters.
  • Ibex Investors's Redhill Biopharma position peaked at $19.2M in Q3 2020.
  • 43 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2022.

Based on Ibex Investors's 13F filing for Q1 2022, filed 29 Apr 2022.